be restricted to hepatocytes in both normal and diseased liver. By immunohistochemistry, no consistent abnormalities in androgen receptor expression were observed in non-neoplastic chronic liver diseases. Interestingly, androgen receptor expression was observed in a significantly greater proportion of women.
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Recently Negro et al'0 developed a nonradioisotopic in situ hybridisation assay specific for the human androgen receptor mRNA. Although no normal liver was examined, androgen receptor mRNA was detected in eight (42%) of 19 non-neoplastic liver specimens, a similar proportion to that found in this study. Androgen receptor mRNA was similarly restricted to hepatocytes, although the proportion of reactive hepatocytes found was noticeably less than in the present study and was never more than 10%. This difference most probably reflects a difference in sensitivity of the two techniques. Indeed, in a test set of frozen sections from five hepatocellular carcinomas (HCCs) stained with a different androgen receptor monoclonal antibody, Negro et al were able to demonstrate androgen receptor protein in only one case, which also expressed androgen receptor mRNA. Two HCCs, strongly positive for the androgen receptor mRNA, were negative by immunohistochemistry and in the remaining two cases, neither androgen receptor protein nor its mRNA could be detected.
Several puted tomography scan was normal but a few metastatic nodules were found on a chest radiograph. Her serum AFP concentration was raised at 280-3 gig/ml. The patient underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy and liver biopsy in November 1993. On the sixth day after surgery, the patient's serum AFP concentration had fallen to 66-9 jig/ml. A course of combination chemotherapy was instituted 10 days after surgery, comprising intraveneous cyclophosphamide (400 mglm2/day) and doxorubicin hydrochloride (40 mg/m2/day) on day 1 and cisplatin (10 mg/m2/day) for seven consecutive days. This regimen was repeated every three weeks. While on chemotherapy the size and number of lung metastases increased as did her serum AFP concentration (to 935-0 gg/ml by the end of January 1994). The patient died on 15 February 1994. A complete necropsy was carried out.
PATHOLOGY
The uterus was diffusely enlarged by the extensive tumour invasion into the myometrium and the uterine cavity was filled with a necrotic, haemorrhagic mass. An extensive tumour embolus formation was seen in the right paraovarian area.
Microscopically, the tumour was composed of a major medullary portion and a minor tubular adenocarcinoma which had invaded the myometrium, the myometrial lymphatics and blood vessels. Neoplastic cells in the medullary portion were polygonal with glycogen-rich cytoplasm. Vascular permeation by neoplastic cells was prominent. Extensive hepatoma-like features were observed (fig 1) .
AFP expression was detected immunohistochemically in all endometrial adenocarcinoma cells and was particularly strong in the hepatoma-like cells. Formalin fixed, paraffin wax embedded tumour sections were stained by the peroxidase-antiperoxidase (PAP) method using rabbit antiserum directed against AFP, and rabbit antiserum and mouse monoclonal antibody directed against human carcinoembryonic antigen (CEA). Tumour cell cytoplasm was AFP positive (fig 2) . In the hepatoma-like cells complex canalicular structures were seen which reacted with the polyclonal (but not the monoclonal) antibody directed against CEA. The necropsy revealed a widespread metastatic proliferation in the lungs. Discussion Serum AFP concentrations are often raised in gynaecological malignancies, such as EST of the ovary. In endometrial adenocarcinoma, however, production of AFP is extremely rare. grated during embryogenesis and remained in the basal layer of the endometrium. One of the AFP producing endometrial tumours was a mixed mesodermal type and it was suggested that malignant transformation ofmullerian epithelial and stromal cells had occurred independently following differentiation of primitive mesenchymal cells into epithelial and stromal components.5 Two other poorly differentiated AFP producing endometrial tumours were papillary adenocarcinomas.67 The latter three AFP producing tumours showed no evidence of yolk sac differentiation. Matsukuma and Tsukamoto6 suggested that the tumour they studied had originated from abnormally differentiated endometrial columnar cells which produced AFP. Kubo et afi concluded that AFP producing tumours may arise from miillerian duct elements. The present case is an example of hepatoid adenocarcinoma of the uterus, because of the close resemblance of the neoplastic cells to hepatoid cells and because of the production ofbile canaliculi-like structures, which reacted with the polyclonal but not the monoclonal antibody directed against CEA. 8 Hepatoid adenocarcinomas have been reported in the genitourinary system, probably as a result of metaplastic or transdifferentiation processes. 9 AFP in the present case was diffusely localised to the cytoplasm. Reverse transcription polymerase chain reaction (RT-PCR) analysis of cDNA generated from the RNA present in the tumour cells using primers specific for AFP demonstrated the expression of AFP mRNA. AFP in the serum of our patient was purified by immunoaffinity chromatography and characterised. The results obtained on SDS polyacrylamide gel electrophoresis both before and after treatment with glycopeptidase F were indistinguishable from those ofhepatoma derived AFP. This indicated that the AFP derived from the tumour was also composed of a single polypeptide chain with a molecular weight of 67000 and one N-linked sugar chain (molecular weight 3000). The 
